portal vein invasion
Showing 1 - 25 of 5,775
Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Seoul (PBT and atezolizumab/bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- Portal Vein Thrombosis
- PBT and atezolizumab/bevacizumab
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 15, 2022
Hepatocellular Carcinoma Trial in Seoul (AtezoBev with combined radiotherapy)
Not yet recruiting
- Hepatocellular Carcinoma
- AtezoBev with combined radiotherapy
-
Seoul, Korea, Republic ofSeverance hospital
Jun 9, 2023
Hepatocellular Carcinoma Trial in Guangzhou (FOLFOX-HAIC, Camrelizumab, Apatinib)
Recruiting
- Hepatocellular Carcinoma
- FOLFOX-HAIC
- +2 more
-
Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
Jan 19, 2022
Hepatocellular Cancer Trial in Shanghai (hepatic resection, Sorafenib)
Recruiting
- Hepatocellular Cancer
- hepatic resection
- Sorafenib
-
Shanghai, ChinaEastern Hepatobiliary Surgery Hospital
Apr 8, 2021
Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- I-125 Seeds Brachytherapy in PVTT
- +2 more
- (no location specified)
Aug 14, 2023
Hepatocellular Carcinoma Trial in Guangzhou (stereotactic body radiotherapy, Sintilimab)
Recruiting
- Hepatocellular Carcinoma
- stereotactic body radiotherapy
- Sintilimab
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 21, 2021
Chronic Portal Vein Thrombosis in Children
Not yet recruiting
- Portal Vein Thrombosis
- endoscopy
- (no location specified)
Nov 3, 2023
HCC With Portal Vein Tumor Thrombosis on Basis of Risk Scoring
Completed
- Hepatocellular Carcinoma
- +2 more
-
Daegu, DalSeo-gu, Korea, Republic ofKeimyung university Dongsan Medical Center
Aug 16, 2023
Portal Vein Thrombosis in Neonate With Umbilical Catheter
Not yet recruiting
- Portal Vein Thrombosis
- ultrasound and doppler
- (no location specified)
Nov 21, 2023
Pre-operative EUS Guided and Intra-operative Direct Portal Vein
Not yet recruiting
- Liver Cirrhosis
- EUS Portal pressure measurement
- (no location specified)
Nov 1, 2023
Portal Hypertension, Liver Diseases, Ascites Hepatic Trial in New York (Scorpion Portal Vein Access Kit, Cook Transjugular Liver
Not yet recruiting
- Portal Hypertension
- +4 more
- Scorpion Portal Vein Access Kit
- +2 more
-
New York, New YorkNew York Presbyterian - Columbia University Irving Medical Cente
Mar 17, 2023
Portal Vein Pulsatility Depending on Fluid Responsivness Status
Not yet recruiting
- Cardiovascular Insufficiency
- Venous Congestion
- (no location specified)
Apr 24, 2023
Portal Hypertension, Portal Vein Thrombosis, Esophageal Varix Bleeding Trial in Chengdu (preemptive TIPS, standard second
Not yet recruiting
- Portal Hypertension
- +3 more
- preemptive TIPS
- standard second prophylaxis
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Nov 3, 2023
Hepatocellular Carcinoma Non-resectable, Portal Vein Tumor Thrombus, Immune Checkpoint Inhibitors Trial in Nanning (Cadonilimab,
Recruiting
- Hepatocellular Carcinoma Non-resectable
- +2 more
- Cadonilimab
- +2 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 13, 2023
Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)
Not yet recruiting
- Primary Hepatocellular Carcinoma
- Portal Vein Thrombosis
- Recombinant human adenovirus type 5 + TACE
- (no location specified)
May 14, 2023
Portal Vein Occlusion isValuable Predictor for Postoperative
Not yet recruiting
- Postoperative Nausea and Vomiting
- this is no intervention
- (no location specified)
Jun 7, 2023
Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)
Not yet recruiting
- Stage IIIA Hepatocellular Carcinoma
- Radiotherapy combined with TKI and Anti-PD-1 Antibody
- (no location specified)
Sep 24, 2023
Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Lenvatinib, Transarterial Chemoembolization (TACE))
Not yet recruiting
- Hepatocellular Carcinoma
- Sintilimab
- +2 more
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 17, 2023
Liver Metastases, Liver Cancer, Liver Tumors Trial in Warsaw (PVE, LVD, ALPPS)
Not yet recruiting
- Liver Metastases
- +3 more
- PVE
- +2 more
-
Warsaw, Mazowieckie, PolandSecond Department of Clinical Radiology
Sep 17, 2023
BA - Biliary Atresia Trial in Aswan (hepato-portoentostomy)
Completed
- BA - Biliary Atresia
- hepato-portoentostomy
-
Aswan, Sahary, EgyptAswan university
Jun 22, 2023
A Practical Nomogram Based on Systemic Inflammatory Markers for
Completed
- Systemic Inflammatory Markers
- Portal Vein Thrombosis
- clinical laboratory tests, and imaging characteristics
-
Qingdao, Shandong, Chinathe Affiliated Hospital of Qingdao University
Sep 13, 2022
Right Portal Vein Diameter
Completed
- Intrauterine Growth Retardation (IUGR)
- Ultrasound
-
Poitiers, FranceC.H.U. de Poitiers
Oct 10, 2022
Deep Vein Thrombosis, Chronic Portal Vein Thrombosis Trial in Clichy (Xarelto)
Completed
- Deep Vein Thrombosis
- Chronic Portal Vein Thrombosis
-
Clichy, FranceHôpital Beaujon
Jul 22, 2022
Hypertension, Portal, Liver Cirrhosis Trial (Placebo, BI 685509)
Not yet recruiting
- Hypertension, Portal
- Liver Cirrhosis
- Placebo
- BI 685509
- (no location specified)
Oct 9, 2023
Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Milan (EUS-guided Portal Vein sampling)
Recruiting
- Pancreatic Cancer
- Pancreatic Adenocarcinoma
- EUS-guided Portal Vein sampling
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Jun 2, 2022